A new treatment for an infant muscle-wasting disease is about to go on sale at a potential cost of $2 million, a record price tag likely to fuel the continuing scrutiny of how companies price their drugs and how insurers pay for them.
Novartis AG has yet to set a price for the gene therapy called Zolgensma, but executives say the drug’s potential to cure spinal muscular atrophy, an inherited disease that typically kills babies before they turn two, justifies a seven-figure price.
$ 2 million.......🤐
There are ~ 380 people per year born with this in the US. How are they supposed to recoup the costs and provide a return to investors?
The free market in action; people get the society they deserve. For those Americans with the bad luck to get a disease like this, it's pay up or die.
Make it $3 million. Who gives a sh**
What’s the point of having a drug people can’t afford
It costs 2m as it is very rare and research & development has cost a lot of money for the company and patenting drugs are very expensive cost tens of millions
I guess it depends on what it cost to create the drug....
Big pharma 101: pick a niche market for a devastating disease and gouge patients to bankruptcy. Patent protection for these companies is garbage and leaves no room for competition to create fair prices
No drug should cost this much.
I don't believe $2 Million is justified. It is Medical Extortion, nothing more!
I'd fly to China and get the generic version for twelve bucks.
I'll take two, please.
This should be classified as a human rights violation.